JP2024517644A5 - - Google Patents

Info

Publication number
JP2024517644A5
JP2024517644A5 JP2023564141A JP2023564141A JP2024517644A5 JP 2024517644 A5 JP2024517644 A5 JP 2024517644A5 JP 2023564141 A JP2023564141 A JP 2023564141A JP 2023564141 A JP2023564141 A JP 2023564141A JP 2024517644 A5 JP2024517644 A5 JP 2024517644A5
Authority
JP
Japan
Prior art keywords
alkyl
lipid
pharmaceutically acceptable
acceptable salt
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023564141A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024517644A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/025455 external-priority patent/WO2022226008A2/en
Publication of JP2024517644A publication Critical patent/JP2024517644A/ja
Publication of JP2024517644A5 publication Critical patent/JP2024517644A5/ja
Pending legal-status Critical Current

Links

JP2023564141A 2021-04-20 2022-04-20 カチオン性脂質及びその組成物 Pending JP2024517644A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163176943P 2021-04-20 2021-04-20
US63/176,943 2021-04-20
US202163217869P 2021-07-02 2021-07-02
US63/217,869 2021-07-02
PCT/US2022/025455 WO2022226008A2 (en) 2021-04-20 2022-04-20 Cationic lipids and compositions thereof

Publications (2)

Publication Number Publication Date
JP2024517644A JP2024517644A (ja) 2024-04-23
JP2024517644A5 true JP2024517644A5 (cg-RX-API-DMAC7.html) 2025-04-28

Family

ID=83723777

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023564141A Pending JP2024517644A (ja) 2021-04-20 2022-04-20 カチオン性脂質及びその組成物

Country Status (11)

Country Link
US (3) US20240226325A1 (cg-RX-API-DMAC7.html)
EP (1) EP4326235A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024517644A (cg-RX-API-DMAC7.html)
KR (1) KR20230172570A (cg-RX-API-DMAC7.html)
AU (1) AU2022262592A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023021504A2 (cg-RX-API-DMAC7.html)
CA (1) CA3215324A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023015501A2 (cg-RX-API-DMAC7.html)
IL (1) IL307758A (cg-RX-API-DMAC7.html)
MX (1) MX2023012369A (cg-RX-API-DMAC7.html)
WO (1) WO2022226008A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2023012369A (es) * 2021-04-20 2024-01-08 Generation Bio Co Lípidos catiónicos y composiciones de estos.
US20260207525A1 (en) * 2022-12-01 2026-07-23 Generation Bio Co. Lipid nanoparticles comprising nucleic acids, ionizable lipids, sterols, lipid anchored polymers and helper lipids, their uses
EP4626402A1 (en) * 2022-12-01 2025-10-08 Generation Bio Co. Lipid nanoparticles comprising nucleic acids and lipid-anchored polymers
AU2023406321A1 (en) * 2022-12-01 2025-05-29 Generation Bio Co. Novel polyglycerol-conjugated lipids and lipid nanoparticle compositions comprising the same
WO2024192528A1 (en) * 2023-03-22 2024-09-26 Nanovation Therapeutics Inc. Ionizable anionic lipids
CN121532216A (zh) * 2023-04-18 2026-02-13 赛仁生物技术公司 腺相关病毒载体组合物和使用方法
EP4719352A1 (en) 2023-05-31 2026-04-08 Capstan Therapeutics, Inc. Lipid nanoparticle formulations and compositions
KR102875269B1 (ko) * 2024-06-03 2025-10-24 주식회사 에스엠엘바이오팜 비대칭 구조를 가지는 지질 화합물 및 이를 포함하는 지질 나노 입자 조성물
WO2026003582A2 (en) 2024-06-27 2026-01-02 Axelyf ehf. Lipids and lipid nanoparticles
WO2026085495A1 (en) 2024-10-18 2026-04-23 Generation Bio Co. Synthetic partially single-stranded nucleic acid compositions and uses and methods therefor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4481047A3 (en) * 2010-06-03 2025-04-16 Alnylam Pharmaceuticals, Inc. Biodegradable lipids for the delivery of active agents
HK1206644A1 (en) * 2012-03-29 2016-01-15 Shire Human Genetic Therapies, Inc. Lipid-derived neutral nanoparticles
WO2013158579A1 (en) * 2012-04-19 2013-10-24 Merck Sharp & Dohme Corp. Novel diester and triester based low molecular weight, biodegradable cationic lipids for oligonucleotide delivery
US10426737B2 (en) * 2013-12-19 2019-10-01 Novartis Ag Lipids and lipid compositions for the delivery of active agents
CA3094057C (en) * 2018-03-27 2025-04-08 Nof Corporation CATIONIC LIPID WITH IMPROVED INTRACELLULAR DYNAMICS
ES2964547T3 (es) * 2018-06-08 2024-04-08 Fujifilm Corp Compuesto, sal del mismo y partículas lipídicas
WO2020058239A1 (en) * 2018-09-18 2020-03-26 Universiteit Gent Therapeutic nanoparticles and methods of use thereof
AU2021307952A1 (en) * 2020-07-17 2023-03-02 Generation Bio Co. Methods for encapsulating polynucleotides into reduced sizes of Lipid nanoparticles and novel formulation thereof
MX2023012369A (es) * 2021-04-20 2024-01-08 Generation Bio Co Lípidos catiónicos y composiciones de estos.

Similar Documents

Publication Publication Date Title
JP2023502576A5 (cg-RX-API-DMAC7.html)
JP2023518985A5 (cg-RX-API-DMAC7.html)
JP2024522692A5 (cg-RX-API-DMAC7.html)
JP2022546597A5 (cg-RX-API-DMAC7.html)
JP2023534043A5 (cg-RX-API-DMAC7.html)
US12252470B2 (en) Lipids and nanoparticle compositions thereof
JP2023527747A5 (cg-RX-API-DMAC7.html)
KR20230052895A (ko) 폴리뉴클레오타이드를 감소된 크기의 지질 나노입자로 캡슐화하는 방법 및 신규한 지질 나노입자 제형
JP2024520756A5 (cg-RX-API-DMAC7.html)
US20240293574A1 (en) Cationic lipids and compositions thereof
US12263228B2 (en) Lipids and compositions thereof
JP2024529343A5 (cg-RX-API-DMAC7.html)
US20230181764A1 (en) Novel lipids and nanoparticle compositions thereof
RU2023129760A (ru) Катионные липиды и их композиции
RU2023135629A (ru) Катионные липиды и их композиции